These drug companies are going nuclear to fight cancer
Big pharma’s investments in nuclear medicine highlight how cancer treatment is shifting to targeted approaches.
Source: livemint.com
Biologics Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biologics Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biologics Engineering Today - Breaking & Trending Today
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
Collaboration Combines Absci’s AI Antibody Drug Creation Platform with AstraZeneca’s Expertise in Oncology Research and DevelopmentVANCOUVER, Wash., Dec. 04, 2023 -- Absci Corporation , a...
Source: marketscreener.com
Exciting opportunity to design new antibody therapy using generative AI
An AI-designed antibody against an oncology target can now be delivered following a collaboration between Absci Corporation and AstraZeneca.
Source: outsourcing-pharma.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: AstraZeneca enters agreement with KYM for CMG901
Investegate announcements from AstraZeneca PLC, AstraZeneca enters agreement with KYM for CMG901
Source: investegate.co.uk
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
/PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global...
Source: prnewswire.com